Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Metadata
Title
Haptoglobin-related protein as a serum marker in malignant lymphoma
Publication date
01-12-1998
Published in
Pathology & Oncology Research / Issue 4/1998
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02905217

Other articles of this Issue 4/1998

Pathology & Oncology Research 4/1998 Go to the issue

Article

Apoptosis and p53 expression in Human Gliomas

Case Report

Leiomyoma of the urinary bladder

Seminar

The Application of Microsatellites in Molecular Pathology

Article

The role of gastric mucosal dysplasia in the development of Gastric Carcinoma

Case Report

Oral focal mucinosis of the Tongue

Seminar

Molecular chaperones in the etiology and therapy of cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits